Stocktoria
LEMAITRE VASCULAR INC LMAT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2006-10-19
LEMAITRE VASCULAR INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M |
| Gross profit | $178.5M | $150.9M | $127.0M | $104.9M | $101.4M |
| R&D expense | $14.1M | $15.7M | $17.0M | $13.3M | $11.8M |
| Operating income | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M |
| Interest expense | $5.2M | $205,000 | $0 | $0 | $2.2M |
| Income tax | $17.4M | $12.8M | $9.4M | $6.9M | $7.4M |
| Net income | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M |
| EPS (diluted) | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 |
| Operating cash flow | $81.3M | $44.1M | $36.8M | $25.4M | $35.1M |
| Cash & equivalents | $28.2M | $25.6M | $24.3M | $19.1M | $13.9M |
| Total assets | $615.7M | $551.8M | $346.8M | $310.5M | $292.8M |
| Total liabilities | $222.2M | $214.5M | $48.9M | $42.3M | $38.7M |
| Shareholders' equity | $393.5M | $337.3M | $297.9M | $268.2M | $254.2M |
Source: SEC EDGAR filings · CIK 0001158895 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.